Editor's note • July 16, 2026
Funny turn this week. The industry spent five years crawling across broken glass to reach the 13-year-old with a ring light — and this week it quietly turned around and started courting the people who actually carry a wallet. Menopause care jumped from four Ulta doors to 448, Estée Lauder decided its tired heritage brands were worth keeping after all, a Nobel chemist put his name next to a serum, and Bath & Body Works bought its way onto Ulta's floor. Read together, it's the same move made four ways: the money is older, calmer, and more patient than the feed ever admitted — and the shelf is finally following the checkbook instead of the birthday.
Receive it daily on your email
For the most demanding audience in the Personal Care and Beauty Industry.
SUBSCRIBE NOW
The Consumer
Naomi Watts' Stripes Beauty jumps from 4 Ulta doors to 448 — menopause care goes mainstream
Summary:
Six months after a pilot in just four 'Wellness by Ulta Beauty' boutiques, Stripes Beauty — founded by actress Naomi Watts — is rolling into 448 Ulta locations from July 26 with a five-SKU in-store set spanning skincare, body care and intimate wellness. Watts will front social content and make in-store appearances. It lands as menopause stops being a whisper and starts being a planogram.
How it shifts the landscape:
A 4-to-448 jump is a retailer deciding an entire life-stage is worth prime square footage. Menopause is projected as a ~$600B opportunity by 2030 (PreScouter), inside a femtech market pegged at $63.1B in 2025 rising toward $267B by 2035 (Astute Analytica) — big enough that 'aging woman' flipped from a marketing problem into a growth thesis. Expect Sephora and mass to answer with their own menopause sets.
Read the full story →
Science & Ingredients
A Nobel chemist puts his name next to a serum: Dr. Peter Agre recognises Emma Lewisham
Summary:
Dr. Peter Agre — awarded the 2003 Nobel Prize in Chemistry for discovering aquaporins — has publicly recognised New Zealand skincare brand Emma Lewisham for its science-led, multi-pathway formulation approach, the first time he's endorsed a beauty brand. Founded in 2019, the brand reached climate-positive certification in 2021 and is stocked by Space NK.
How it shifts the landscape:
A reputation trade, not a clinical claim — Agre is endorsing a mindset, not certifying an efficacy result, which matters in a week regulators keep spanking brands for 'clinically proven' overreach. But it signals where credibility is migrating: away from influencer swatch videos toward borrowed academic authority. When a molecular biologist is the ambassador, 'science-backed' becomes a person willing to attach their name.
Read the full story →
Supply Side
Givaudan takes an equity stake in Switzerland's Microcaps to own precision encapsulation
Summary:
Givaudan announced an equity investment and strategic collaboration with Swiss company Microcaps AG to scale its patented high-precision microencapsulation — with a specific focus on non-alcoholic fine-fragrance performance. Leadership called encapsulation 'one of the most transformative technologies in our field,' aimed at longer-lasting scent across fragrance, skincare and personal care.
How it shifts the landscape:
The tell is 'non-alcoholic.' As EU allergen rules tighten and alcohol-free formats grow, the hard problem moves from what the scent is to how you make it last without the old solvent crutch — a delivery-science problem, not a perfumer's. By buying into the capsule, Givaudan locks up the plumbing the category will need, the same delivery-tech land-grab seen with spicules and exosome carriers.
Read the full story →
Deals & M&A
Estée Lauder decides Too Faced, Smashbox and Dr. Jart+ are worth keeping after all
Summary:
After running a sale process — with final bids reportedly submitted and at least one buyer wanting all three — Estée Lauder has chosen to keep Too Faced, Smashbox and Dr. Jart+, running them with 'significantly streamlined teams,' per an internal note from CEO Stéphane de La Faverie reviewed by The Business of Beauty. ELC paid an estimated $1.45B for Too Faced in 2016; FY2025 net sales fell 8% and operating margin swung from +6.2% to −5.5%, with $375M in Dr. Jart+ impairments and $50M on Too Faced. The restructuring bill now sits at ~$1.748B.
How it shifts the landscape:
'We couldn't get our price' is the honest translation of 'we've decided to keep them.' When bids came in below what a wounded conglomerate would accept, holding and shrinking beat selling at a loss — a reality-check on the celebrity/indie-acquisition boom, where giants overpaid for faces and are now marking them down. The strategic buyer who paid $1.45B in 2016 is the same one writing $375M impairments in 2025.
Read the full story →
Retail & Media
Bath & Body Works buys its way onto Ulta's floor — 600+ stores, and Wall Street liked it
Summary:
Starting July 12, Bath & Body Works began selling a curated set — signature body care, home fragrance, candles, Wallflowers and the revived cult scent Juniper Breeze — across more than 600 Ulta Beauty stores and Ulta.com. For B&BW it's an escape from mall-only distribution; for Ulta it fills what it called a 'meaningful whitespace' in home fragrance, hand soap and body care. ULTA shares rose roughly 6.4% on the news.
How it shifts the landscape:
Two retailers admitting they can't grow alone. B&BW needs traffic that isn't dying with the mall; Ulta needs the mass-fragrance dollars it was leaving on the table as its Target shop-in-shop era winds down. A ~6.4% pop says the market reads 'distribution + category gap filled' as free growth — but it also blurs the line between prestige-adjacent Ulta and the everyday drugstore aisle.
Read the full story →